Ovarian reserve in patients with multiple sclerosis: A systematic review and meta‐analysis
International Journal of Gynecology & Obstetrics · 2023
DOI: 10.1002/ijgo.14757 ↗Kurz gefasst
Metaanalyse in der Zeitschrift International Journal of Gynecology & Obstetrics, 2023. Verfasst von Luigi Carbone und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Naples, Italy. Hauptthemen laut MEDLINE: Ovarian Reserve, Multiple Sclerosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 52 Literaturangaben.
Abstract (Originalsprache)
Objective
To summarize recent evidence about ovarian reserve markers in women affected by multiple sclerosis (MS) compared with healthy controls, as women with MS seem to be characterized by lower anti‐Müllerian hormone (AMH) levels.
Methods
The research was conducted using PubMed (MEDLINE), Scopus, ClinicalTrial.gov , OVID and Cochrane Library from inception of each database to June 30, 2022. Studies comparing ovarian reserve markers between women with MS and healthy controls were considered eligible for inclusion. The primary outcome was serum AMH (ng/mL) levels. Results were reported as pooled odds ratio (OR) for categorical outcomes and as mean difference (MD) for continuous variables, with their 95% confidence intervals (CIs). The random effect model of DerSimonian and Laird was adopted for all analyses. A P ‐value less than 0.05 was considered significant.
Results
Serum AMH circulating levels were not significantly different (MD −0.25, 95% CI −0.83 to 0.32; P = 0.390), as well as blood levels of follicle‐stimulating hormone or ovarian volume. However, antral follicle count (AFC) and estradiol blood levels were significantly lower, and luteinizing hormone (LH) levels were significantly higher in women with MS than in controls.
Conclusion
A significant difference in AFC, estradiol and LH levels was observed, but not for AMH levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Naples, Italy.
- Department of Mental Health and Public Medicine, Unit of Medical Statistics, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.
- Multiple Sclerosis Clinical and Research Unit, University Hospital of Rome Tor Vergata, Rome, Italy.
ORCID-Profile: Luigi Carbone, Raffaella Di Girolamo
Zitieren
APA
Carbone, L., Di Girolamo, R., Conforti, A., Iorio, G. G., Simeon, V., Landi, D., Marfia, G. A., Lanzillo, R., & Alviggi, C. (2023). Ovarian reserve in patients with multiple sclerosis: A systematic review and meta‐analysis. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.14757
Vancouver
Carbone L, Di Girolamo R, Conforti A, Iorio GG, Simeon V, Landi D, et al. Ovarian reserve in patients with multiple sclerosis: A systematic review and meta‐analysis. International Journal of Gynecology & Obstetrics. 2023. doi:10.1002/ijgo.14757
BibTeX
@article{Carbone2023,
author = {Carbone, Luigi and Di Girolamo, Raffaella and Conforti, Alessandro and Iorio, Giuseppe Gabriele and Simeon, Vittorio and Landi, Doriana and Marfia, Girolama Alessandra and Lanzillo, Roberta and Alviggi, Carlo},
title = {Ovarian reserve in patients with multiple sclerosis: A systematic review and meta‐analysis},
journal = {International Journal of Gynecology & Obstetrics},
year = {2023},
doi = {10.1002/ijgo.14757}
}
EUVIMED